Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute myocardial infarction complicated with cardiogenic shock~* Patient without contraindication to IABP or ECLS-Impella~Exclusion Criteria:~* Patient with refractory cardiogenic shock~* Reperfusion \> 24 hours after the pain begins

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): IABP, inotropic drugs, antiplatelet agents according to site habits.
- Experimental (Type: EXPERIMENTAL): ECLS +/- IABP, inotropic drugs, antiplatelet agents according to site habits.

Based on this trial design, predict the completion outcome and termination type (if applicable).